Formula & Concentration
VIMPAT (lacosamide)* Tablet, Film Coated for Oral use
VIMPAT (lacosamide)* Injection for Intravenous use
Vimpat® (lacosamide) CV is indicated 1) for the treatment of partial-onset seizures in patients 1 month of age and older 2) as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in patients 4 years of age and older
Shelf Life and Storage
Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F). [See USP Controlled Room Temperature]
*VIMPAT is a Schedule V controlled substance.